Natco Pharma appoints Amit Parekh as new Executive Vice President - Finance and Accounts

Written By :  Ruchika Sharma
Published On 2025-12-02 08:10 GMT   |   Update On 2025-12-02 08:10 GMT
Advertisement

Telangana: Natco Pharma has announced the appointment of Amit Parekh as its new Executive Vice President - Finance and Accounts of the Company.

This strategic move is a part of the company’s structured succession planning.

As per the recent BSE filing, subject to necessary approvals; Amit Parekh will succeed S.V.V.N. Appa Rao, Chief Financial Officer of the Company at the Board meeting to be held in the month of February 2026.
Advertisement
Amit Parekh has more than 20 years of experience, with a proven track record of managing financial and business affairs for top Indian companies in diverse industries, including healthcare, pharma, mining and engineering, telecommunications, and chemicals. Few of his core competencies are CXO Level engagements, Investment & M&A (including in & out licencing deals in Pharma space), Cost leadership Projects, Financial Analysis and Reporting, Financial Management & Accounting (IFRS, IND AS, US GAAP) and Risk Assessment & Compliance, etc., he was previously associated with Dr. Reddy’s Laboratories Limited as Head of Finance -API and Pharmaceutical Services (PSAI) and Head of Digital Transformation in Finance. 

Natco Pharma Limited is a public limited company, listed on the Bombay Stock Exchange and the National Stock Exchange of India, with a market capitalisation of c. US$ 2 billion. Established in 1981, NATCO Pharma has evolved into a diversified pharmaceutical manufacturer, with a primary focus on research and development, manufacturing, and global marketing of both finished dosage formulations and active pharmaceutical ingredients. NATCO Pharma operates across various geographies (in over 50 countries), including emerging and developed markets, with a particular focus on delivering quality medicines in oncology, cardiology, neurology, and other high-value therapeutic categories.

Read also: Natco Pharma to buy significant stakes in South African Drugmaker Adcock Ingram

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News